CN Stock MarketDetailed Quotes

Xiangxue Pharmaceutical (300147)

Watchlist
  • 9.96
  • +0.15+1.53%
Market Closed Apr 8 15:00 CST
6.59BMarket Cap-6.57P/E (TTM)

Xiangxue Pharmaceutical (300147) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Traditional Chinese medicine529.88M64.78%
Other187.28M22.89%
Antivirus oral liquid64M7.82%
Orange series36.84M4.50%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Traditional Chinese medicine529.88M64.78%
Pharmaceutical manufacturing125.6M15.35%
Total special adjustments113.82M13.91%
Pharmaceutical circulation34.93M4.27%
medical apparatus9.63M1.18%
Other business4.13M0.51%
View all

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
North, East and Northeast China621.34M75.96%
Guangdong province190.09M23.24%
Southwest region15.64M1.91%
Central China-9.07M-1.11%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More